CordenPharma is making a record investment of >€1 billion over the next 3 years in building and / or expanding small,medium,and large peptide manufacturing facilities across Europe and the US.

- XPOVIO® is the first and only approved XPO1 inhibitor in Indonesia. - From the second half of 2024 to now,XPOVIO®was successively approved in Thailand,Malaysia and Indonesia,significantly e

Priority Pass,the world\'s leading airport lounge and experiences programme,owned and operated by Collinson International,teams up with Filipino Elite Motorsport racing star in latest show of support

Debut project to be unveiled soon at Al Marjan Island,Ras Al Khaimah,in collaboration with Zaha Hadid Architects

STOCKHOLM,March 2,2025-- Aduna,a landmark venture between some of the world\'s leading telecom operators and Ericsson,is set to partner with Bridge Alliance to accelerate the adoption of CAMARA-based